Exane Derivatives’s Nebius Group N.V. NBIS Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIS
TIM
Exane Derivatives's NBIS Position: Q2 2017 in Review
Exane Derivatives sold out of Nebius Group N.V. (NBIS) in Q2 2017, closing a stake of 3,590 shares — an estimated $78.7K sold.
Exane Derivatives first reported a position in NBIS in Q4 2016 and held it in 2 quarters. The position peaked at $78.7K in Q1 2017. 231 funds tracked by Wall St. Rank hold NBIS as of Q2 2017.
- Exane Derivatives reported no remaining Nebius Group N.V. position as of Q2 2017 after selling out during the quarter.
- Exane Derivatives sold 3,590 Nebius Group N.V. shares in Q2 2017, an estimated $78.7K.
- Exane Derivatives first reported a position in Nebius Group N.V. in Q4 2016 and held it in 2 quarters.
- Exane Derivatives's Nebius Group N.V. position peaked at $78.7K in Q1 2017.
- 231 funds tracked by Wall St. Rank held Nebius Group N.V. as of Q2 2017.
Based on Exane Derivatives's 13F filing for Q2 2017, filed 17 Jul 2017.